Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002470 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Xingyu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Innovative Research Groups of Hubei Province.
Abstract (Originalsprache)
The bridging integrator 1 (BIN1) gene is an important risk locus for late-onset Alzheimer’s disease (AD). BIN1 protein has been reported to mediate tau pathology, but the underlying molecular mechanisms remain elusive. Here, we show that neuronal BIN1 is cleaved by the cysteine protease legumain at residues N277 and N288. The legumain-generated BIN1 (1–277) fragment is detected in brain tissues from AD patients and tau P301S transgenic mice. This fragment interacts with tau and accelerates its aggregation. Furthermore, the BIN1 (1–277) fragment promotes the propagation of tau aggregates by enhancing clathrin-mediated endocytosis (CME). Overexpression of the BIN1 (1–277) fragment in tau P301S mice facilitates the propagation of tau pathology, inducing cognitive deficits, while overexpression of mutant BIN1 that blocks its cleavage by legumain halts tau propagation. Furthermore, blocking the cleavage of endogenous BIN1 using the CRISPR/Cas9 gene-editing tool ameliorates tau pathology and behavioral deficits. Our results demonstrate that the legumain-mediated cleavage of BIN1 plays a key role in the progression of tau pathology. Inhibition of legumain-mediated BIN1 cleavage may be a promising therapeutic strategy for treating AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Department of Anatomy and Neurobiology, Central South University Xiangya School of Medicine, Changsha, China.
- Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China.
- TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
ORCID-Profile: Xingyu Zhang, Zhentao Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Innovative Research Groups of Hubei Province
- China Postdoctoral Science Foundation
- Foundation for Innovative Research Groups of Hubei Province
- New 20 Terms of Universities in Jinan
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhang, X., Zou, L., Tang, L., Xiong, M., Yan, X. X., Meng, L., Chen, G., Xiong, J., Nie, S., Zhang, Z., Chen, Q., & Zhang, Z. (2024). Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002470
Vancouver
Zhang X, Zou L, Tang L, Xiong M, Yan XX, Meng L, et al. Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002470
BibTeX
@article{Zhang2024,
author = {Zhang, Xingyu and Zou, Li and Tang, Li and Xiong, Min and Yan, Xiao-Xin and Meng, Lanxia and Chen, Guiqin and Xiong, Jing and Nie, Shuke and Zhang, Zhaohui and Chen, Qiang and Zhang, Zhentao},
title = {Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002470}
}
EUVIMED